Guidelines for Safe Singleton Vaginal Birth (SVB)
The preferred mode of delivery is vaginal with an individualized delivery plan that includes timing, method of induction if needed, analgesia/regional anesthesia, and required monitoring level. 1
Pre-Delivery Planning
Timing of Delivery
- Spontaneous onset of labor is appropriate for women with normal cardiac function and is preferable to induced labor for most women 1
- Timing should be individualized according to:
- Maternal cardiac status
- Bishop score (cervical readiness)
- Fetal well-being
- Lung maturity
Labor Induction (When Medically Indicated)
- Oxytocin and artificial rupture of membranes are indicated when the Bishop score is favorable 1
- Avoid long induction times with unfavorable cervix
- For mechanical cervical ripening, a Foley catheter is preferable to pharmacological agents 1
- Misoprostol (Cytotec) should not be used for cervical preparation or induction in the third trimester for women with previous cesarean delivery due to high risk (13%) of uterine rupture 1
- Dinoprostone is contraindicated in active cardiovascular disease due to profound effects on blood pressure 1
Intrapartum Management
Maternal Positioning
- Lateral decubitus position during labor to attenuate the hemodynamic impact of uterine contractions 1
Monitoring During Labor
- Continuous monitoring of:
- Systemic arterial pressure
- Maternal heart rate
- Pulse oximetry and continuous ECG as required 1
- Swan-Ganz catheter is rarely if ever indicated due to risks of arrhythmia, bleeding, and thromboembolic complications 1
Pain Management
- Lumbar epidural analgesia is recommended because it:
- Reduces pain-related elevations of sympathetic activity
- Reduces the urge to push
- Provides anesthesia for surgery if needed 1
- Monitor intravenous perfusion carefully with regional anesthesia, especially in patients with obstructive valve lesions 1
Delivery Management
Second Stage
- Allow uterine contractions to descend the fetal head to the perineum without maternal exhaustion
- Consider assisted vaginal delivery (forceps or vacuum) when indicated:
Post-Delivery Management
- Administer slow IV infusion of oxytocin (<2 U/min) after placental delivery to prevent maternal hemorrhage while avoiding systemic hypotension 1
- For postpartum hemorrhage control:
- Prostaglandin F analogues can treat post-partum hemorrhage unless an increase in pulmonary artery pressure is undesirable 1
- Methylergonovine is contraindicated due to risk (>10%) of vasoconstriction and hypertension 1
Special Considerations
Previous Cesarean Delivery
- For women with previous vaginal birth, encourage planning for labor after cesarean (LAC)/vaginal birth after cesarean (VBAC) unless specific contraindications exist 1
- About 74% of U.S. women who try LAC have a successful vaginal birth 1
- Short-term maternal outcomes are as good or better with LAC/VBAC versus repeat cesarean delivery 1
- Repeat cesarean delivery increases long-term risk of abnormal placentation, hysterectomy, and surgical complications compared with VBAC 1
Cardiovascular Disease
- Vaginal delivery is associated with less blood loss and infection risk compared to cesarean delivery 1
- Cesarean delivery should be considered for:
- Patients on oral anticoagulants in pre-term labor
- Marfan syndrome with aortic diameter >45 mm
- Acute or chronic aortic dissection
- Acute intractable heart failure 1
- Some centers advocate cesarean delivery for women with severe aortic stenosis, severe pulmonary hypertension, or acute heart failure 1
Postpartum Care
- Continue hemodynamic monitoring for at least 24 hours after delivery, as this period involves important hemodynamic changes and fluid shifts that may precipitate heart failure 1
- Implement meticulous leg care, elastic support stockings, and early ambulation to reduce thromboembolic risk 1
Common Pitfalls to Avoid
- Prolonged induction with unfavorable cervix
- Using misoprostol in women with previous cesarean delivery
- Inadequate monitoring during and after delivery
- Rapid administration of oxytocin causing hypotension
- Using methylergonovine in women with cardiovascular disease
- Delaying intervention when progress stalls or fetal distress occurs
By following these guidelines, healthcare providers can optimize outcomes for both mother and baby during singleton vaginal birth, minimizing morbidity and mortality while ensuring the best quality of life.